Your session is about to expire
← Back to Search
Early Weight Bearing for Ankle Fracture
N/A
Recruiting
Led By Lisa Reider, PhD
Research Sponsored by Major Extremity Trauma Research Consortium
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Surgically treated open or closed fractures of the ankle meeting specific criteria: bimalleolar fracture requiring fixation of any two malleoli, bimalleolar equivalent SER4 fractures, trimalleolar fracture with fixation of at least two malleoli, operative treatment of an isolated lower extremity unicondylar tibial plateau fracture without joint impaction
Be older than 18 years old
Must not have
Third degree burns on >10% total surface area affecting the study limb
Fractures and dislocations to the lower limb affecting weight bearing, upper limb injuries limiting weight bearing, injuries to other body systems affecting compliance with weight bearing protocol
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing whether it's better to wait or start bearing weight immediately after surgery for an ankle fracture.
Who is the study for?
Adults over 18 with certain types of ankle or tibial plateau fractures that have been surgically treated can join this trial. Excluded are those with severe soft tissue injuries, syndesmotic injuries, upper limb weight-bearing limitations, morbid obesity (BMI ≥40), psychiatric disorders affecting compliance, and other conditions like neuropathy or osteoporosis.
What is being tested?
The study is examining the effects of allowing patients to put weight on their leg early after surgery for an ankle fracture without syndesmotic fixation or a specific type of tibial plateau fracture. It compares early versus delayed weight bearing in terms of rehabilitation outcomes.
What are the potential side effects?
Since the intervention involves early weight bearing rather than medication, side effects may include pain at the injury site, potential stress to healing bones or joints, and risk of re-injury if the bone has not healed sufficiently.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I had surgery for a specific type of broken ankle or lower leg bone.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have severe burns on more than 10% of my body, including the limb being studied.
Select...
I have injuries that prevent me from putting weight on my arms or legs.
Select...
I have nerve damage or a broken bone due to cancer.
Select...
I have osteoporosis, confirmed by medication use or a past weak-bone fracture.
Select...
I have had surgery to fix an injury in my ankle joint.
Select...
I have a severe injury to my leg that prevents me from putting weight on it.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Number of Study Related Complications Experienced
Return to Usual Major Activity and Work Productivity
Secondary study objectives
Joint Range of Motion (ROM)
Pain Interference
Pain Score
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Early Weight BearingExperimental Treatment1 Intervention
Patients with ankle fractures will be instructed to weight bear as tolerated (WBAT) while in a boot with a heel to toe normal gait and wean from walker or crutches to a cane or no support device. At the 6 week post op visit, patients with ankle fractures will be instructed to wean from the boot and continue full weight bearing as tolerated until full weight bearing is achieved. Patients with plateau fractures will be instructed to begin WBAT until full weight bearing is achieved.
Group II: Delayed Weight BearingActive Control1 Intervention
Patients with ankle fractures will be instructed to touch-down (toe touch or foot flat) weight bear (approximately 10% of body weight) while in the boot for. Patients will be instructed to keep foot off of floor or set ball of foot or heal on ground for balance using walker or crutches at all times. After the 6 week post op visit, patients may begin weight bearing as tolerated. Patients with tibial plateau fractures will be instructed to touch down (toe touch or foot flat) weight bear (approximately 10% of body weight) for at least 6 weeks. After the 6 week post op visit, patients may begin weight bearing as tolerated until full weight bearing is achieved.
Find a Location
Who is running the clinical trial?
Major Extremity Trauma Research ConsortiumLead Sponsor
31 Previous Clinical Trials
27,006 Total Patients Enrolled
Lisa Reider, PhDPrincipal InvestigatorMajor Extremity Trauma Research Consortium
4 Previous Clinical Trials
983 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I had surgery for a specific type of broken ankle or lower leg bone.I have severe burns on more than 10% of my body, including the limb being studied.I have injuries that prevent me from putting weight on my arms or legs.I have nerve damage or a broken bone due to cancer.I have osteoporosis, confirmed by medication use or a past weak-bone fracture.I have had surgery to fix an injury in my ankle joint.I have a severe injury to my leg that prevents me from putting weight on it.I am 18 years old or older.I have a specific type of knee fracture and may have mobility or health issues that could affect my treatment.
Research Study Groups:
This trial has the following groups:- Group 1: Delayed Weight Bearing
- Group 2: Early Weight Bearing
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger